RADIATION SENSITIZERS AND BIOREDUCTIVE DRUGS

辐射增敏剂和生物还原药物

基本信息

  • 批准号:
    2096375
  • 负责人:
  • 金额:
    $ 72.97万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1992
  • 资助国家:
    美国
  • 起止时间:
    1992-09-30 至 1996-09-29
  • 项目状态:
    已结题

项目摘要

This Program Project application combines the different expertise of four collaborating laboratories to perform research on the radiation sensitizing and bioreductive activity in cancer of novel compounds including bifunctional and other nitroheterocyclic agents, fused pyrazine mono-N- oxides and quinonoid analogs of mitomycin C. The four projects which comprise this application and their general objectives are: Project 1. Identification and Evaluation of Bioreductive Drugs. The broad aim of this project is to optimize the selection and development of novel bioreductive drugs that may be used as clinical radiation sensitizers and hypoxia-selective drugs for use in chemotherapy. Project 2. Microenvironments and Effectiveness of Bioreductive Drugs in Spheroids. Multicellular tumor spheroids of human and rodent cell lines will be used to assess structure-activity relationships for cytotoxicity and chemosensitization, and the role of cell microenvironments. Project 3. Efficacy and Mechanisms of Bioreductive Drugs as Chemosensitizing Agents. The central goal of this project is to determine the effectiveness and mechanisms of action of these bioreductive drugs as in vitro and in vivo hypoxic cell cytotoxins or chemopotentiating agents. Project 4. Mechanisms of Oncogenic Transformation by Bioreductive Drugs. The basic aim is to elucidate the mechanisms and factors that determine oncogenicity and provide input to identify the ideal physico-chemical properties of a bioreductive drug. Information provided by the experiments in these four projects will be integrated to guide the development of a new generation of bioreductive drugs for application in the treatment and diagnosis of cancer.
这个程序项目应用程序结合了四个不同的专业知识

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROBERT M SUTHERLAND其他文献

ROBERT M SUTHERLAND的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROBERT M SUTHERLAND', 18)}}的其他基金

HYPOXIA STRESS GENES IN VITRO AND IN SOLID TUMORS
体外和实体瘤中的缺氧应激基因
  • 批准号:
    6300485
  • 财政年份:
    2000
  • 资助金额:
    $ 72.97万
  • 项目类别:
HYPOXIA STRESS GENES IN VITRO AND IN SOLID TUMORS
体外和实体瘤中的缺氧应激基因
  • 批准号:
    6103065
  • 财政年份:
    1999
  • 资助金额:
    $ 72.97万
  • 项目类别:
HYPOXIA STRESS GENES IN VITRO AND IN SOLID TUMORS
体外和实体瘤中的缺氧应激基因
  • 批准号:
    6269706
  • 财政年份:
    1998
  • 资助金额:
    $ 72.97万
  • 项目类别:
HYPOXIA STRESS GENES IN VITRO AND IN SOLID TUMORS
体外和实体瘤中的缺氧应激基因
  • 批准号:
    6237558
  • 财政年份:
    1997
  • 资助金额:
    $ 72.97万
  • 项目类别:
EGF SIGNAL TRANSDUCTION AND RADIATION RESPONSE
EGF 信号传导和辐射响应
  • 批准号:
    2098063
  • 财政年份:
    1994
  • 资助金额:
    $ 72.97万
  • 项目类别:
EGF SIGNAL TRANSDUCTION AND RADIATION RESPONSE
EGF 信号传导和辐射响应
  • 批准号:
    2098064
  • 财政年份:
    1994
  • 资助金额:
    $ 72.97万
  • 项目类别:
EGF SIGNAL TRANSDUCTION AND RADIATION RESPONSE
EGF 信号传导和辐射响应
  • 批准号:
    2098065
  • 财政年份:
    1994
  • 资助金额:
    $ 72.97万
  • 项目类别:
RADIATION SENSITIZERS AND BIOREDUCTIVE DRUGS
辐射增敏剂和生物还原药物
  • 批准号:
    2096376
  • 财政年份:
    1992
  • 资助金额:
    $ 72.97万
  • 项目类别:
RADIATION SENSITIZERS AND BIOREDUCTIVE DRUGS
辐射增敏剂和生物还原药物
  • 批准号:
    3094580
  • 财政年份:
    1992
  • 资助金额:
    $ 72.97万
  • 项目类别:
RADIATION SENSITIZERS AND BIOREDUCTIVE DRUGS
辐射增敏剂和生物还原药物
  • 批准号:
    3094579
  • 财政年份:
    1992
  • 资助金额:
    $ 72.97万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了